Editorial Board
- Nanomedicine and Nanotechnology Section
- Pharmaceutical Technology, Manufacturing and Devices Section
- Physical Pharmacy and Formulation Section
- Biopharmaceutics Section
- Drug Delivery and Controlled Release Section
- Pharmacokinetics and Pharmacodynamics Section
- Gene and Cell Therapy Section
- Drug Targeting and Design Section
- Biologics and Biosimilars Section
- Clinical Pharmaceutics Section
Please note that the order in which the Editors appear on this page is alphabetical, and follows the structure of the editorial board presented on the MDPI website under information for editors: editorial board responsibilities.
Members
Interests: lung cancer; NSCLC; SCLC; mesothelioma; immunotherapy; target therapy; new drugs; tumor biomarkers
Interests: target discovery and validation; drug discovery and development; assay design and optimization; chemogenomics
Special Issues, Collections and Topics in MDPI journals
Interests: hydrogels; drug delivery systems; antitumor therapy; immunotherapy; localized delivery; oral peptide delivery; tissue adhesive materials; cell culture
Interests: molecular glasses; bioavailability vs. physical stability; mesoporous silica; biopreservation; deep-eutectic solvents
Special Issues, Collections and Topics in MDPI journals
2. Signalling Research Centres BIOSS and CIBSS, 79085 Freiburg, Germany
3. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada
Interests: liposomal drug delivery systems; mixed micelles; calorimetry; model membranes; drug-membrane interactions; biophysics
Interests: drug formulation and delivery; long-acting injectables; physical pharmacy; lipid-based formulations; cyclodextrins
Special Issues, Collections and Topics in MDPI journals
Interests: blood-retinal barrier; blood-brain barrier; transporter
Interests: sustained drug release; hydrogels; stimuli-responsive drug delivery; pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: targeted drug delivery; combined cancer therapy; biomaterials
Interests: oral, topical, and transdermal delivery; nanoparticle; microemulsion; oral dosage forms design
Special Issues, Collections and Topics in MDPI journals
Interests: novel Ru-based nanosystems for cancer therapy
Special Issues, Collections and Topics in MDPI journals
2. Clinical Biotechnology Team, Center for Infectious Disease Education and Research (CiDER), Osaka University, 1-1 Yamadaoka, Suita, Osaka 565-0871, Japan
Interests: mRNA therapeutics; regenerative medicine; synthetic biology
Special Issues, Collections and Topics in MDPI journals
Interests: bioceramics; drug delivery systems; nanomedicine; bone tissue regeneration; surface functionalization; targeting therapies; inorganic nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: decorin; syndecan; proteoglycan; tenomodulin; R-Ras; homing peptide; angiogenesis; hypoxia
Interests: biopharmaceuticals; stability; formulation; quality; machine learning; physicochemical properties
Special Issues, Collections and Topics in MDPI journals
Interests: iron oxides biomineralization; carbonate biomineralization; biomimetic magnetic nanoparticles
Interests: colon-targeted drug delivery; prodrug; codrug; pathologically-targeted drug; molecular pharmacology of anti-colitic agents
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; particle engineering; formulation development; dry powder inhalers
Special Issues, Collections and Topics in MDPI journals
Interests: molecular imaging; theranostics; drug delivery
Interests: drug–drug interaction; metabolomics; drug metabolism and pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: bionanomaterIals; enzyme; catalysis and regulation; magnetic nanoparticles and magbetic field; nanomedicine; drug delivery and drug carriers; Protein-containing nanoparticles; Proteins and their modification
2. Bioengineering R&D Center Kragujevac, Kragujevac, Serbia
3. Serbian Academy of Science and Arts, Belgrade, Serbia
Interests: drug delivery; computational models; physiological barriers; drug vectors; implant devices; imaging analysis; immunotherapy; microenvironment; intra-tumoral pharmacokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; drug resistance; cancer therapy; toxicity
Special Issues, Collections and Topics in MDPI journals
Interests: nanomedicine; targeted drug delivery; gene therapy; ultrasound-mediated drug and gene delivery
Special Issues, Collections and Topics in MDPI journals
Interests: membrane transport; transporter; blood-brain barrier; blood-retinal barrier; blood-testis barrier; microphysiological systems
2. Institute of Biomedical Research of Salamanca (IBSAL), 37007 Salamanca, Spain
Interests: drug delivery; cell carriers; nanoparticles; pharmacokinetics; anti-infectives; pharmaceutical development
Special Issues, Collections and Topics in MDPI journals
Interests: preclinical and clinical PET imaging; tissue distribution of drugs; biological barriers; membrane transporters; drug-drug interactions; radiotracer development; ADME; clinical pharmacokinetics; clinical pharmacology; microdosing
Interests: drug therapy and drug delivery systems in retinal and eye diseases
Interests: membrane transporters; drug-drug interactions (DDI); drug elimination; DDI-related adverse drug reactions; clinical data warehouse; prescriptome analytics
Interests: solubilization; bioavailability; particle technologies; lipid-based drug delivery; formulation design
Special Issues, Collections and Topics in MDPI journals